Schattner A, Shtalrid M, Levy R, Berrebi A
Isr J Med Sci. 1981 Jun;17(6):433-6.
Although indomethacin has been implicated as a possible cause of aplastic anemia on the basis of a few clinical observations, its role has not been definitely established. A case of fatal aplastic anemia is described in which no drugs other than allopurinol and indomethacin were given. Indomethacin was first given four weeks prior to the onset of symptoms. A positive lymphocyte transformation test with indomethacin in vitro further substantiates the potential role of this drug in causing aplastic anemia in a susceptible patient. Fortunately, this seems to be a very rare complication.
尽管基于一些临床观察,吲哚美辛被认为可能是再生障碍性贫血的一个病因,但其作用尚未明确确立。本文描述了一例致命性再生障碍性贫血病例,该患者除别嘌醇和吲哚美辛外未使用其他药物。吲哚美辛在症状出现前四周首次使用。体外吲哚美辛淋巴细胞转化试验呈阳性,进一步证实了该药物在易感患者中导致再生障碍性贫血的潜在作用。幸运的是,这似乎是一种非常罕见的并发症。